FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048703611> ?p ?o ?g. }

• W3048703611 endingPage "51" @default.
• W3048703611 startingPage "41" @default.
• W3048703611 abstract "In postmenopausal women at high risk of fracture, we previously reported that combined denosumab and high-dose (HD; 40 μg) teriparatide increased spine and hip bone mineral density (BMD) more than combination with standard-dose teriparatide (SD; 20 μg). To assess the effects of these combinations on bone microarchitecture and estimated bone strength, we performed high-resolution peripheral quantitative computed tomography (HR-pQCT) at the distal radius and distal tibia in these women, who were randomized to receive either teriparatide 20 μg (n = 39) or 40 μg (n = 37) during months 0 to 9 overlapped with denosumab 60 mg s.c. given at months 3 and 9, for a 15-month study duration. The 69 women who completed at least one study visit after baseline are included in this analysis. Over 15 months, increases in total BMD were higher in the HD-group than the SD-group at the distal tibia (5.3% versus 3.4%, p = 0.01) with a similar trend at the distal radius (2.6% versus 1.0%, p = 0.06). At 15 months, cortical porosity remained similar to baseline, with absolute differences of -0.1% and -0.7% at the distal tibia and -0.4% and -0.1% at the distal radius in the HD-group and SD-group, respectively; p = NS for all comparisons. Tibial cortical tissue mineral density increased similarly in both treatment groups (1.3% [p < 0.0001 versus baseline] and 1.5% [p < 0.0001 versus baseline] in the HD-group and SD-group, respectively; p = 0.75 for overall group difference). Improvements in trabecular microarchitecture at the distal tibia and estimated strength by micro-finite element analysis at both sites were numerically greater in the HD-group compared with SD-group but not significantly so. Together, these findings suggest that short-term treatment combining denosumab with either high- or standard-dose teriparatide improves HR-pQCT measures of bone density, microstructure, and estimated strength, with greater gains in total bone density observed in the HD-group, which may be of benefit in postmenopausal women with severe osteoporosis. © 2020 American Society for Bone and Mineral Research (ASBMR)." @default.
• W3048703611 created "2020-08-18" @default.
• W3048703611 creator A5024994311 @default.
• W3048703611 creator A5027689644 @default.
• W3048703611 creator A5032638450 @default.
• W3048703611 creator A5040613178 @default.
• W3048703611 creator A5055429927 @default.
• W3048703611 creator A5074596928 @default.
• W3048703611 creator A5089621353 @default.
• W3048703611 date "2020-09-19" @default.
• W3048703611 modified "2023-10-18" @default.
• W3048703611 title "Effects of Combination Denosumab and <scp>High‐Dose</scp> Teriparatide Administration on Bone Microarchitecture and Estimated Strength: The <scp>DATA‐HD HR‐pQCT</scp> Study" @default.
• W3048703611 cites W1500340499 @default.
• W3048703611 cites W1840449490 @default.
• W3048703611 cites W1963733296 @default.
• W3048703611 cites W1965154023 @default.
• W3048703611 cites W1966877738 @default.
• W3048703611 cites W1976854024 @default.
• W3048703611 cites W1989880575 @default.
• W3048703611 cites W1993457878 @default.
• W3048703611 cites W2011416167 @default.
• W3048703611 cites W2021542350 @default.
• W3048703611 cites W2030294284 @default.
• W3048703611 cites W2045561758 @default.
• W3048703611 cites W2052991153 @default.
• W3048703611 cites W2057096224 @default.
• W3048703611 cites W2060784455 @default.
• W3048703611 cites W2066056548 @default.
• W3048703611 cites W2081877806 @default.
• W3048703611 cites W2086904058 @default.
• W3048703611 cites W2092654589 @default.
• W3048703611 cites W2102177673 @default.
• W3048703611 cites W2110396808 @default.
• W3048703611 cites W2113523811 @default.
• W3048703611 cites W2136906270 @default.
• W3048703611 cites W2139586263 @default.
• W3048703611 cites W2139785110 @default.
• W3048703611 cites W2143508491 @default.
• W3048703611 cites W2144065099 @default.
• W3048703611 cites W2152578289 @default.
• W3048703611 cites W2170373155 @default.
• W3048703611 cites W2238735150 @default.
• W3048703611 cites W2295122297 @default.
• W3048703611 cites W2566815969 @default.
• W3048703611 cites W2585649126 @default.
• W3048703611 cites W2801978743 @default.
• W3048703611 cites W2902807692 @default.
• W3048703611 cites W2969940759 @default.
• W3048703611 cites W2985892442 @default.
• W3048703611 doi "https://doi.org/10.1002/jbmr.4161" @default.
• W3048703611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32790196" @default.
• W3048703611 hasPublicationYear "2020" @default.
• W3048703611 type Work @default.
• W3048703611 sameAs 3048703611 @default.
• W3048703611 citedByCount "6" @default.
• W3048703611 countsByYear W30487036112021 @default.
• W3048703611 countsByYear W30487036112022 @default.
• W3048703611 countsByYear W30487036112023 @default.
• W3048703611 crossrefType "journal-article" @default.
• W3048703611 hasAuthorship W3048703611A5024994311 @default.
• W3048703611 hasAuthorship W3048703611A5027689644 @default.
• W3048703611 hasAuthorship W3048703611A5032638450 @default.
• W3048703611 hasAuthorship W3048703611A5040613178 @default.
• W3048703611 hasAuthorship W3048703611A5055429927 @default.
• W3048703611 hasAuthorship W3048703611A5074596928 @default.
• W3048703611 hasAuthorship W3048703611A5089621353 @default.
• W3048703611 hasBestOaLocation W30487036111 @default.
• W3048703611 hasConcept C126322002 @default.
• W3048703611 hasConcept C126894567 @default.
• W3048703611 hasConcept C141071460 @default.
• W3048703611 hasConcept C2776286101 @default.
• W3048703611 hasConcept C2776541429 @default.
• W3048703611 hasConcept C2776886416 @default.
• W3048703611 hasConcept C2777236700 @default.
• W3048703611 hasConcept C2777308945 @default.
• W3048703611 hasConcept C2777425516 @default.
• W3048703611 hasConcept C2779329777 @default.
• W3048703611 hasConcept C2989005 @default.
• W3048703611 hasConcept C71924100 @default.
• W3048703611 hasConceptScore W3048703611C126322002 @default.
• W3048703611 hasConceptScore W3048703611C126894567 @default.
• W3048703611 hasConceptScore W3048703611C141071460 @default.
• W3048703611 hasConceptScore W3048703611C2776286101 @default.
• W3048703611 hasConceptScore W3048703611C2776541429 @default.
• W3048703611 hasConceptScore W3048703611C2776886416 @default.
• W3048703611 hasConceptScore W3048703611C2777236700 @default.
• W3048703611 hasConceptScore W3048703611C2777308945 @default.
• W3048703611 hasConceptScore W3048703611C2777425516 @default.
• W3048703611 hasConceptScore W3048703611C2779329777 @default.
• W3048703611 hasConceptScore W3048703611C2989005 @default.
• W3048703611 hasConceptScore W3048703611C71924100 @default.
• W3048703611 hasFunder F4320337362 @default.
• W3048703611 hasFunder F4320337375 @default.
• W3048703611 hasIssue "1" @default.
• W3048703611 hasLocation W30487036111 @default.
• W3048703611 hasLocation W30487036112 @default.
• W3048703611 hasOpenAccess W3048703611 @default.
• W3048703611 hasPrimaryLocation W30487036111 @default.

• next